Journal of South Asian Association of Pediatric Dentistry

Register      Login

VOLUME 4 , ISSUE 1 ( January-June, 2021 ) > List of Articles

REVIEW ARTICLE

Pediatric Dental Management in COVID-19 Era: A Contemporary Outlook

Gyanendra Kumar, Francisco Ramos-Gomez, Jatinder K Dhillon, Neetika Singh, Ferah Rehman

Keywords : Hand hygiene, Healthcare professionals, Pediatric dentistry, Personal protective equipment

Citation Information : Kumar G, Ramos-Gomez F, Dhillon JK, Singh N, Rehman F. Pediatric Dental Management in COVID-19 Era: A Contemporary Outlook. J South Asian Assoc Pediatr Dent 2021; 4 (1):33-40.

DOI: 10.5005/jp-journals-10077-3073

License: CC BY-NC 4.0

Published Online: 00-06-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

The pandemic of coronavirus disease-2019 (COVID-19), which originally started in Wuhan city of China, has become a major public health challenge for not only China but also other countries around the globe. The World Health Organization announced that the outbreaks of the novel coronavirus have constituted a public health emergency of international concern. Infection control measures are necessary to prevent the virus from further spreading and to help control the pandemic situation. The risk of cross-infection may be high between dental practitioners and patients because of the unique nature of functioning of dentistry especially pediatric dentistry. Therefore, we require urgent implementation of strict and effective infection control protocols for dental practices and hospitals in nations inflicted with COVID-19. This paper will provide some basic preventive measures required in pediatric dental settings and management protocols for dental practitioners and students to prevent the spread of the COVID-19 nosocomial infection in (potentially) affected areas and maintain a healthy environment for patients and dental team.


PDF Share
  1. World Health Organization, WHO Director-General's Remarks at the Media Briefing on 2019-nCoV on 11 February 2020; 2020. Available online: https://www.who.int/dg/ speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11february-2020.
  2. Available online at: http://www.who.int/COVID-19/information-Coronavirus disease 2019 (COVID-19) Situation Report – 78. Data as received by WHO from national authorities by 10:00 CET, 5th May 2020).
  3. World Health Organization, WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. Available online: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefingon-covid-19-11-march-2020.
  4. Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 2020;58(4):712–713. DOI: 10.1542/peds.2020-0702.
  5. Foster CE, Moulton EA, Munoz FM, et al. Coronavirus disease 2019 in children cared for at Texas children's hospital: initial clinical characteristics and outcomes. J Pediatric Infect Dis Soc 2020;9(3):373–377. DOI: 10.1093/jpids/piaa072.
  6. Xu H, Liu E, Xie J, et al. A follow-up study of children infected with SARS-CoV-2 from western China. Ann Transl Med 2020;8(10):623. DOI: 10.21037/atm-20-3192.
  7. Shekerdemian LS, Mahmood NR, Wolfe KK, et al. International COVID-19 PICU collaborative. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr 2020;174(9):1–6. DOI: 10.1001/jamapediatrics.2020.1948.
  8. Mannheim J, Gretsch S, Layden JE, et al. Characteristics of hospitalized pediatric COVID-19 cases - Chicago, Illinois, March - April 2020. J Pediatric Infect Dis Soc 2020. piaa070.
  9. Assaker R, Colas AE, Julien-Marsollier F, et al. Presenting symptoms of COVID-19 in children: a meta-analysis of published studies. Br J Anaesth 2020;125(3):e330–e332. DOI: 10.1016/j.bja.2020.05.026.
  10. Poline J, Gaschignard J, Leblanc C, et al. Systematic SARS-CoV-2 screening at hospital admission in children: a French prospective multicenter study. Clin Infect Dis 2020. ciaa1044.
  11. Information for Pediatric Healthcare Providers. Available on: https://www.cdc.gov/coronavirus/ 2019-ncov/hcp/pediatric-hcp.html, updated on august 14,2020. Accessed September 2, 2020.
  12. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet 2020;395(10223):497–506. DOI: 10.1016/S0140-6736(20)30183-5.
  13. Qiu H, Wu J, Hong L, et al. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang. China Observat Cohort Study Lancet Infect Dis 2020;20(6). DOI: 10.1016/S1473-3099(20)30198-5.
  14. Cruz AT, Zeichner SL. COVID-19 in children: Initial characterization of the pediatric disease. Pediatrics. 2020;145(6):e20200834. DOI: 10.1542/peds.2020-0834. Epub 2020 Mar 16. PMID: 32179659.
  15. Hoang A, Choratha K, Moreirab A, et al. COVID-19 in 7780 pediatric patients: a systematic review. EClinicalMedicine 2020;24:100433. DOI: 10.1016/j.eclinm.2020.100433.
  16. To KKW, Tsang OTY, Yip CCY, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis 2020;71(15):841–843. DOI: https://doi.org/10.1093/cid/ciaa149.
  17. Fan C, Lei D, Fang C, et al. Perinatal transmission of COVID-19 associated SARS-CoV- 2: Should we worry? Clin Infect Dis 2020. ciaa226. Online ahead of print https://doi.org/10.1093/cid/ciaa226.
  18. Mallineni SK, Innes NP, Raggio DP, et al. Coronavirus disease (COVID-19): characteristics in children and considerations for dentists providing their care. Int J Paediatr Dent 2020;30(3):245–250. DOI: https:// doi.org/10.1111/ipd.12653.
  19. Drugs for the Management of Dental Problems During COVID-19 Pandemic. Scottish Dental Clinical Effective Programme (SDcep) NHS Education of Scotland, 8 April 2020 (Last accessed on25 April 2020)] Available online: http://www.sdcep.org.uk/wp-content/uploads/2020/04/SDCEP-MADP-COVID-19-drug-supplement-080420.pdf.
  20. Available online at: https://www.cdc.gov/niosh/topics/hierarchy/default.html. Last accessed on June 27, 2020.
  21. Day M. COVID-19: ibuprofen should not be used for managing 297 symptoms, say doctors and scientists. BMJ 2020;368:m1086. DOI: /10.1136/bmj.m1086.
  22. Li Y, Wing-Hong S, Natural Ventilation for infection control in health care settings. WHO (2009). Avaible online: https://www.who.int/water_sanitation_health/publications/natural_ventilation.pdf.
  23. ISHRAE COVID-19 Guidance Document for Air Conditioning and Ventilation. Available at: https://ishrae.in/mailer/ISHRAE_COVID-19_Guidelines.pdf.
  24. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579(3):270–273. DOI: 10.1038/s41586-020-2012-7.
  25. Meng L, Hua F, Bian Z. Coronavirus disease 2019 (COVID- 19): emerging and future challenges for dental and oral medicine. J Dent Res 2020;99(5):481–487. DOI: 10.1177/0022034520914246.
  26. Checchi L, Montevecchi M, MoreschiA, et al. Efficacy of three face masks in preventing inhalation of airborne contaminants in dental practice. JADA 2005;136(7):877–882. DOI: 10.14219/jada.archive.2005.0288.
  27. Radonovich LJ, Simberkoff MS, Bessesen MT, et al. N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial. JAMA 2019;322(9):824–833. DOI: 10.1001/jama.2019.11645.
  28. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382(1):727–733. DOI: 10.1056/NEJMoa2001017.
  29. WHO. Infection prevention and control of epidemic-and pandemic-prone acute respiratory infections in health care. Geneva, Switzerland: World Health Organization; 2014. Available at: https://www.who.int/publications/i/item/infection-prevention-and-control-of-epidemic-and-pandemic-prone-acute-respiratory-infections-in-health-care
  30. Montevecchi M, Checchi V, Felice P, et al. Management rules of the dental practice: individual protection devices. Dent Cadmos 2012;80(5):247–263. DOI: 10.1016/j.cadmos.2011.11.007.
  31. Eggers M, Koburger-Janssen T, Eickmann M, et al. In vitro bactericidal and virucidal efficacy of povidone-iodine gargle/mouthwash against respiratory and oral tract pathogens. Infect Dis Ther 2018;7(2):249–259. DOI: 10.1007/s40121-018-0200-7.
  32. Teilleier R, Li Y, Cowling BJ, et al. Recognition of aerosol transmission of infectious agents: a commentary. BMC Infect Dis 2019;19(1):101. DOI: 10.1186/s12879-019-3707-y.
  33. Netz RR. Mechanisms of airborne infection via evaporating and sedimenting droplets produced by speaking. J Phys Chem B 2020;124(33):7093–7101. DOI: 10.1021/acs.jpcb.0c05229.
  34. Thamboo A, Lea J, Sommer DD, et al. Clinical evidence based review and recommendations of aerosol generating medical procedures in otolaryngology - head and neck surgery during the COVID-19 pandemic. J Otolaryngol Head Neck Surg 2020;49(1):28. DOI: 10.1186/s40463-020-00425-6.
  35. Harrel SK, Molinari J. Aerosols and splatter in dentistry: a brief review of the literature and infection control implications. J Am Dent Assoc 2004;135(4):429–437. DOI: 10.14219/jada.archive.2004.0207.
  36. Ricci ML, Fontana S, Pinci F, et al. Pneumonia associated with a dental unit waterline. Lancet 2012;379(9816):684. DOI: 10.1016/S0140-6736(12)60074-9.
  37. Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 2020;382(10):970–971. DOI: 10.1056/NEJMc2001468.
  38. COVID-19 guidelines and standard operating procedures. Urgent dental care system in the context of Coronavirus. NHS England and NHS Improvement. Version 1, 15 April 2020 (Publications approval reference:001559) https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/879111/T4_poster_Recommended_PPE_additional_considerations_of_COVID-19.pdf.
  39. Cochran MA, Miller CH, Sheldrake MA. The efficacy of 293 the rubber dam as a barrier to the spread of microorganisms during 294 dental treatment. J Am Dent Assoc 1989;119(1):141–144. DOI: 10.14219/jada.archive.1989.0131.
  40. Peng X, Xu X, Li Y, et al. Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci 2020;12(1):1–6. DOI: 10.1038/s41368-020-0075-9.
  41. Alharbi A, Alharbi S, Alquidi S. Guidelines for dental care provision during the COVID-19 pandemic. Saudi Dent J 2020;32(4):181–186. DOI: 10.1016/j.sdentj.2020.04.001.
  42. Samaranayake LP, Reid J, Evans D. The efficacy of rubber dam isolation in reducing atmospheric bacterial contamination. ASDC J Dent Child 1989;56:442–444.
  43. Hu T, Li G, Zuo Y, et al. Risk of hepatitis B virus transmission via dental handpieces and evaluation of an anti-suction device for prevention of transmission. Infect Control Hosp Epidemiol 2007;28(1):80–82. DOI: 10.1086/510808.
  44. Kampf G, Todt D, Pfaender S, et al. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hospital Infect 2020;104(30):246–251. DOI: 10.1016/j.jhin.2020.01.022.
  45. Public Heath England. Guidance; Reducing the risk of transmission of COVID-19 in hospital setting. Updated 17 April 2020. Available online: https://www.gov.uk/government/publications/wuhan-novel-coronavirus-infection-prevention-and-control/reducing-the-risk-of-transmission-of-covid-19-in-the-hospital-setting#contents (Last accessed on 23 April 2020).
  46. Wang WK, Chen SY, Liu IJ, et al. Detection of SARS- associated coronavirus in throat wash and saliva in early diagnosis. Emerg Infect Dis 2004;10(7):1213–1219. DOI: 10.3201/eid1007.031113.
  47. Rubin R. Difficult to determine herd immunity threshold for COVID-19. JAMA 2020;324(8):732. DOI: 10.1001/jama.2020.14785.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.